Close button
The Guardian
Email YouTube Facebook Instagram Twitter WhatsApp

USA, LUTH reaffirm commitment to transform cancer treatment


Accounts Manager, Ogonna Oraegbunam (left); Head, Access, Yetunde Oyeneyin; Chief Medical Director (CMD) of Lagos University Teaching Hospital (LUTH) Idi Araba, Prof. Chris Bode; Country Group Head, Novartis, Babatunde Ojo; and Head, Medical Affairs of Novartis Nigeria, Adeline Edgal, on a medical outreach to LUTH on Tuesday

The United States Trade and Development Agency and Lagos University Teaching Hospital (LUTH), Idi-Araba have reiterated its commitment towards transforming Nigeria’s healthcare system to optimise service delivery.

Speaking at a courtesy visit to the new cancer centre in LUTH, the Acting Director, United States Trade and Development Agency, Thomas Hardy, said the facility is a testament to the great leadership of hospital management.

Hardy said as an agency, they are investing in people and entities that have similar vision and ability to achieve great things.

“They leadership of the hospital came to U.S., we introduced them to American technology and cancer treatment solutions in a bid to transform Nigeria healthcare system for accessible and quality care. We will continue to be in contact with the team to find other opportunities where we will have such dramatic impact,” he said.


Chief Medical Director (CMD), LUTH, Professor Chris Bode, said the U.S. agency visited to witness the progress they have made so far citing that innovations like this will reverse brain drain and medical tourism.

Bode said: “This centre is pride for Nigeria and West Africa. The promise this centre comes with is that we will guarantee optimal service to everyone who comes here. Our services are going to be cheaper than anything you can get in Nigeria, or abroad generally.”

According to the CMD, the centre boasts of ultra-modern equipment can treat up to 300 patients from not Nigeria only but also patients from our neighboring countries.

He continued: “A group of investors came and brought their money to establish this centre. We are determined to render good services consistently for the next ten years and beyond so that investors will make their money back. We will render services to those who will come. This facility will run consistently. There should be no down time because we paid for maintenance, routine services, breakdown and repair.

“The five percent downtime is for routine maintenance. We call on the government, philanthropists, investors to come let us think of innovative ways to finance health care so that people can afford and access quality care.”

Bode noted replicating such facility is imperative in reversing the trend of medical tourism because people are now trusting the care system.

“As we speak we are approaching experts from other institutions abroad, we are poised to bring some Nigerians homes who are already expert in the area of cancer,” he noted


In this article:
LUTHProfessor Chris Bode
Receive News Alerts on Whatsapp: +2348136370421

No comments yet